You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • THU0136 Long Term Outcomes of Stopping Tumour Necrosis Factor Inhibitors (TNFI) in Patients with Established Rheumatoid Arthritis (RA) Who are in Sustained Remission: Is it Worth the Risk?

Citation Tools

Article menu
Download PDFPDF
Poster Presentation
Rheumatoid arthritis - prognosis, predictors and outcome
THU0136 Long Term Outcomes of Stopping Tumour Necrosis Factor Inhibitors (TNFI) in Patients with Established Rheumatoid Arthritis (RA) Who are in Sustained Remission: Is it Worth the Risk?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Rakieh C, Saleem B, Takase K, et al
THU0136 Long Term Outcomes of Stopping Tumour Necrosis Factor Inhibitors (TNFI) in Patients with Established Rheumatoid Arthritis (RA) Who are in Sustained Remission: Is it Worth the Risk?
Annals of the Rheumatic Diseases 2013;72:A208-A209.